SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-14-006927
Filing Date
2014-02-13
Accepted
2014-02-13 15:18:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 63941
2 MISCELLANEOUS EXHIBITS misc1.htm EX-99.1 5644
  Complete submission text file 0001140361-14-006927.txt   71439
Mailing Address PO BOX 900 ZURICH V8 CH 8070
Business Address PO BOX 900 FHLS ZURICH V8 CH 8070 41 1 212 16 16
CREDIT SUISSE AG/ (Filed by) CIK: 0000824468 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Subject) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-86638 | Film No.: 14605463
SIC: 2834 Pharmaceutical Preparations